Trademark: 87982774
Status Date
Tuesday, April 21, 2020
Registration Number
6037766
Registration Date
Tuesday, April 21, 2020
Filing Date
Thursday, January 12, 2017
Published for Opposition
Tuesday, December 5, 2017
42 Biochemical research and development; Biological research; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Scientific research consulting in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research consulting in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research consulting in the field of serious and life threatening diseases; Scientific research for medical purposes in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research for medical purposes in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research for medical purposes in the field of serious and life threatening diseases; Research in the field of pharmacogenetics; Conducting clinical trials for others in the field of pharmaceuticals; Research services in the field of proteins, antibodies, microorganisms and cells; Research and development services in the field of antibody technology; Structural and functional analysis of genomes; DNA screening for scientific research purposes; Biochemical research and analysis; research and development services in the field of immunology
Apr 11, 2024
Teas Change Of Correspondence Received
Apr 11, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 11, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 26, 2021
Teas Change Of Correspondence Received
Oct 26, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 26, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 26, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 21, 2020
Registered-Principal Register
Mar 17, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 15, 2020
Allowed Principal Register - Sou Accepted
Feb 26, 2020
Statement Of Use Processing Complete
Jan 27, 2020
Use Amendment Filed
Feb 26, 2020
Divisional Processing Complete
Jan 27, 2020
Divisional Request Received
Feb 26, 2020
Case Assigned To Intent To Use Paralegal
Jan 27, 2020
Teas Request To Divide Received
Jan 27, 2020
Teas Statement Of Use Received
Jun 27, 2019
Teas Change Of Correspondence Received
Jun 27, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 25, 2019
Sou Extension 3 Granted
Jun 25, 2019
Sou Extension 3 Filed
Jun 25, 2019
Sou Teas Extension Received
Jan 9, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2019
Sou Extension 2 Granted
Jan 7, 2019
Sou Extension 2 Filed
Jan 7, 2019
Sou Teas Extension Received
Jul 21, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 19, 2018
Sou Extension 1 Granted
Jul 19, 2018
Sou Extension 1 Filed
Jul 19, 2018
Sou Teas Extension Received
Jan 30, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 5, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2017
Published For Opposition
Nov 15, 2017
Notification Of Notice Of Publication E-Mailed
Oct 26, 2017
Approved For Pub - Principal Register
Oct 25, 2017
Teas/Email Correspondence Entered
Oct 24, 2017
Correspondence Received In Law Office
Oct 24, 2017
Teas Response To Office Action Received
Apr 28, 2017
Combined Examiner's Amendment/Priority Action Entered
Apr 28, 2017
Assigned To Lie
Apr 28, 2017
Notification Of Examiner's Amendment/Priority Action E-Mailed
Apr 28, 2017
Examiner's Amendment/Priority Action E-Mailed
Apr 28, 2017
Examiners Amendment And/Or Priority Action - Completed
Apr 6, 2017
Assigned To Examiner
Jan 19, 2017
New Application Office Supplied Data Entered
Jan 16, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
